Israel now offering Regeneron as multiple studies show significantly lowers COVID mortality

Thursday, September 23, 2021 | Tag Cloud Tags: , , , , , ,

coronavirus israel worthy christian news

(Worthy News) – On Wednesday of this week, Israel’s Health Ministry announced that the Regeneron monoclonal antibody blend would henceforth be offered to COVID-19 patients considered at high risk of progressing to serious illness.

Regeneron is a combination of two substances, casirivimab and imdevimab, that have been found to be significantly effective in preventing mild cases of coronavirus from progressing to serious illness and death. Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens. Casirivimab and imdevimab are specifically directed against the spike protein of COVID-19, designed to block the virus’ attachment and entry into human cells.

The drugs’ effectiveness in combination were confirmed as early as November of 2020 by the FDA, which granted emergency use authorization (EUA) for the treatment of mild to moderate COVID-19 for anyone over the age of 12. [ Source: Arutz Sheva (Read More…) ]

We're being CENSORED ... HELP get the WORD OUT! SHARE!!!
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.

Worthy Christian News